A month has gone by since the last earnings report for Sarepta Therapeutics, Inc.SRPT. Shares have lost about 9.9% in that time frame, underperforming the market. Will the recent negative trend continue leading up to the stock's next …
Succeeding 13 years of R&D with a commercial-level rare disease drug, Sarepta …
Below is a chart showing FLWS's trailing twelve month trading history, with the $7.50 strike highlighted in orange: And Sarepta Therapeutics Inc (SRPT) saw options trading volume of 11,459 contracts, representing approximately 1.1 …
Geduld E E sold 19,359 shares as Sarepta Theraputics Inc (SRPT)’s stock rose 22.49%. The Geduld E E holds 11,000 …
Perceptive Advisors Llc increased Sarepta Therapeutics (SRPT) stake by 25311.28% reported in 2016Q4 SEC ... 1,000 were reported by Segment Wealth …
A stock rating usually tells investors how well a stock's market ... Massachusetts …
Live Day Trading Stock Charts, Live Day Trading Day Trading, Live Day Trading Pull Backs, Live Day Trading $STX, Live Day Trading $SRPT, Live Day Trading $AAPL, Live Day Trading $SPY, Live Day Trading $NFLX, Live Day Trading $FB, …
Of those analysts, 10 rate stock as a Strong Buy, 9 rate it as Hold ... Among 24 analysts covering Sarepta Therapeutics (NASDAQ:SRPT), 18 have Buy rating, 1 Sell and 5 Hold. Therefore 100% are positive. Aspen Technology has $6200 …